A drug used for breast and ovarian cancer is more effective than modern targeted hormone An innovative new treatment for prostate cancer.
A new study suggests that combining a breast cancer drug with hormone therapy could be a more effective strategy to reduce the progression and recurrence of prostate cancer in men. Hormone therapy, or androgen deprivation therapy (ADT), is a common treatment for prostate cancer.
The drug 'olaparib' was trialled in men with advanced prostate cancer who were no longer responding to hormone treatment.
A breast cancer drug has been used to double the survival of men with result represents a revolution in the treatment of prostate cancer.